Letter: Pimozide in monosymptomatic psychosis

Hypoxia induces differential expression of the integrin receptors alpha(vbeta3) and alpha(vbeta5) in cultured human endothelial cells.

Journal of cellular biochemistry·2000

Inhibition of neointima formation by a nonpeptide alpha(v)beta(3) integrin receptor antagonist in a rabbit cuff model.

Journal of cellular biochemistry·2000

Disposition and exposure of the fibrinogen receptor antagonist XV459 on alphaIIBbeta3 binding sites in the guinea pig.

Biopharmaceutics & drug disposition·2000

Alphavbeta3 integrin binding affinity and specificity of SM256 in various species.

Journal of cardiovascular pharmacology·1999

Orally active isoxazoline glycoprotein IIb/IIIa antagonists with extended duration of action.

Journal of medicinal chemistry·1999

Prothrombin activation in rabbits.

Thrombosis research·1999

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Methodological considerations for designing and conducting open-label placebo trials.

Pain·2026

Efficacy of intravenous ketamine for neuropathic pain: a systematic review and meta-analysis of randomized clinical trials.

Pain management·2026

Data-driven in silico toxicity profiling of marketed drugs and retrospective analysis of post-marketing withdrawal risk.

Toxicology mechanisms and methods·2026

Influence of sex, anxiety, and risk-taking behavior on opioid and alcohol polysubstance consumption patterns.

Addiction neuroscience·2026

Assessing the Safety of Medications During Lactation: Lactation safety.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG·2026

Timing of Intraoperative Dexmedetomidine Administration and Post-anaesthesia Care Unit Recovery: A Single-Centre Quality Improvement Audit.

Cureus·2026

Related Experiment Videos

Letter: Pimozide in monosymptomatic psychosis

Related Concept Videos

Hypoxia induces differential expression of the integrin receptors alpha(vbeta3) and alpha(vbeta5) in cultured human endothelial cells.

Inhibition of neointima formation by a nonpeptide alpha(v)beta(3) integrin receptor antagonist in a rabbit cuff model.

Disposition and exposure of the fibrinogen receptor antagonist XV459 on alphaIIBbeta3 binding sites in the guinea pig.

Alphavbeta3 integrin binding affinity and specificity of SM256 in various species.

Orally active isoxazoline glycoprotein IIb/IIIa antagonists with extended duration of action.

Prothrombin activation in rabbits.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Methodological considerations for designing and conducting open-label placebo trials.

Efficacy of intravenous ketamine for neuropathic pain: a systematic review and meta-analysis of randomized clinical trials.

Data-driven in silico toxicity profiling of marketed drugs and retrospective analysis of post-marketing withdrawal risk.

Influence of sex, anxiety, and risk-taking behavior on opioid and alcohol polysubstance consumption patterns.

Assessing the Safety of Medications During Lactation: Lactation safety.

Timing of Intraoperative Dexmedetomidine Administration and Post-anaesthesia Care Unit Recovery: A Single-Centre Quality Improvement Audit.

Related Experiment Videos

Letter: Pimozide in monosymptomatic psychosis

Related Concept Videos

Related Articles